CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase ... results of its next-generation weight loss drug CagriSema. After a late-stage trial slightly missed expectations, the ...

President Trump’s proposed tariffs on Denmark could have costly consequences for Americans relying on GLP-1 medications like Ozempic and Wegovy—and consumers are becoming increasingly concerned.

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs ... cases of a rare eye condition after concerns it could be linked to Ozempic.

Around 2.3 million Medicare patients used Novo drugs made with semaglutide - which includes Ozempic, Wegovy and Rybelsus ... Novo Nordisk were already down before the publication of the list ...

Your guide to what the 2024 US election means for Washington and the world Prices for Novo Nordisk’s blockbuster diabetes and weight-loss drugs Ozempic and Wegovy ... in the US after the ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 ... Services Secretary Xavier Becerra told reporters. “It lets us go after the biggest cost drivers in the prescription drug field for ...